Enter assignee name

Forward Citations = 166

Loading Chart...

4 inventors (with patents filed for the assignee):

Jennifer A Doudna (20 out of 138 patents)

Martin Jinek (20 out of 66 patents)

Krzysztof Chylinski (20 out of 62 patents)

4. Emmanuelle Charpentier (20 out of 61 patents)

20 patents: Sort by Forward Citations

1. 11549127 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2023-01-10),

2. 11186849 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-11-30),

3. 11008590 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-05-18),

4. 11001863 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-05-11),

5. 10988782 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-04-27),

6. 10982231 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-04-20),

7. 10982230 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-04-20),

8. 10900054 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2021-01-26),

9. 10612045 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2020-04-07),

10. 10570419 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2020-02-25),

11. 10563227 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2020-02-18),

12. 10533190 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2020-01-14),

13. 10526619 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2020-01-07),

14. 10428352 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2019-10-01),

15. 10385360 - Methods and compositions for RNA-directed target DNA modification and for RNA-directed modulation of transcription (2019-08-20),

Emmanuelle Charpentier is a French microbiologist and biochemist. She is best known for her groundbreaking research on CRISPR-Cas9, a revolutionary genome editing technology. She co-discovered the potential of CRISPR-Cas9 for genome editing applications, leading to a paradigm shift in genetic research and its potential applications in medicine, agriculture, and various industries. Emmanuelle Charpentier has received numerous awards and honors for her contributions to science and is widely recognized as one of the leading figures in the field of genetic engineering.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 16 2025

20 Patents

#51 in D-1000 Berlin

#2,237 in Germany

#30,324 in the World

Berlin, Germany

Emmanuelle Charpentier

Forward Citations = 166

4 inventors:

Jennifer A Doudna (20 out of 138 patents)

Martin Jinek (20 out of 66 patents)

Krzysztof Chylinski (20 out of 62 patents)

4. Emmanuelle Charpentier (20 out of 61 patents)

Please report any incorrect information to support@idiyas.com